Restricted accessLetterFirst published online 1997-4
Long Term Therapy for Uremic Bleeding: Effects of Conjugate Estrogens on the Expression of Platelet Surface Receptors for von Willebrand Factor and Fibrinogen (GPIb and GPIIb/IIIa Glycoproteins)
SloandJ.A.Long term therapy for uremic bleeding. Int J Artif Organs1996; 19: 439–40.
2.
SloandE.M., SloandJ.A., ProdouzK.Reduction of platelet glycoprotein lb in uremia. Br J Haematol1991; 77: 375–81.
3.
LianiM., SalvatiF., GolatoM., TrescaE.Platelet glycoproteins GPIb and GPIIb/IIIa abnormalities in uremia. Nephron1996; 72: 716.
4.
LianiM., SalvatiF., TrescaE.Bleeding diathesis in uremic patients treated with peritoneal dialysis: role of platelet glycoproteins GPIb and GPIIb/llla abnormalities. Nephron1996; 74: 234.
5.
GawazM.P., DobosG., SpathM.Impaired function of platelet membrane glycoprotein IIb IIIa in end stange renal disease. J Am Soc Nephrol1994; 5: 36–46.
6.
SloandE.M., KesslerC.M., SloandJ.A.DDVAP corrects the platelet dysfunction produced by cardiopulmonary by-pass, hemodialysis, and prolonged storage: Re-expression of GPIb on the platelet membrane. New York: Plenum Press, Desmopressin in Bleeding Dis1993; 147–54.
7.
AkizawaT., KinugasaE., KiiaokaT., KoshitawaS.Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients. Nephron1991; 58: 400–6.
8.
LianiM., SalvatiF., NubileG., TrescaE., VelussiC., MidrioM.von Willebrand factor and rise in ristocetin cofactor with erythropoietin. Lancet1993; 341: 1221.
9.
LianiM., SalvatiF., TrescaE., Di PaoloG., VitacolonnaL., GolatoM., VelussiC.Arteriovenous fistula obstruction and expression of platelet receptors for von Willebrand factor and for fibrinogen (glycoproteins GPIb and GPIIb/IIIa) in hemodialysis patients. Int J Artif Organs1996; 19: 451–4.
